Also. . .

Irish drug maker Elan Corp. said that it agreed to acquire Neurex Corp., a Menlo Park-based drug maker specializing in pain medication, in a stock swap worth $700 million. Elan, based in Dublin, has spent $2 billion making acquisitions in the last two years. The company is branching into a new area with the acquisition of Neurex and its drugs to treat pain.